Gabi Tellez

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant challenges of male infertility. We recognize the critical gap in male fertility treatment and are committed to helping people on their path to parenthood. Our innovative in-vitro spermatogenesis (IVS) technology is poised to transform the fertility landscape, offering new hope and innovative solutions to those struggling to conceive. Led by a team of world-renowned scientists and physicians, we are advancing research into clinical applications. Our mission is to make parenthood a reality for more families through ethical, scientifically advanced fertility solutions. Did you know? *1 in 8 couples struggle with infertility. *50% of in vitro fertilization (IVF) procedures fail. *50% of infertility is linked to men. *Male infertility treatment has been stagnant since 1992. Paterna is the first to develop a truly new treatment for male infertility since then. With a strong foundation in science and a commitment to innovation, Paterna BioSciences is uniquely positioned to lead the next generation of male fertility treatments. We are actively seeking funding to accelerate our clinical development and commercialization efforts, bringing our life-changing technology to families worldwide. We help make parenthood possible. Learn more at www.PaternaBio.com Contact us: info@paternabio.com A New Paradigm in Human Reproduction.

Purgo Scientific is a medical device company developing a novel method for targeted therapeutic drug delivery. While there are many applications for this method, the initial goal is to treat and prevent biofilm-related surgical site infections that compromise indwelling devices such as orthopedic implants. Targeted drug delivery against biofilms with local, high dose concentrations of antibiotic have a better chance at treating these infections than other therapies. In the United States alone, each year this problem affects as many as 300,000 people and costs the healthcare system up to $10 billion. The ultimate goal for our device is to extend its application beyond the eradication of biofilm-caused infections, and to treat any health issue that benefits from precise medicine delivery, including pain and oncology applications.

Front desk tasks at a healthcare practice are time-consuming and largely repetitive. Stratus provides AI solutions that allows your practice to focus on what matters most – your patients.

Authentiface, Inc. is a startup that transforms authentication with its facial motion analysis technology. Based in Utah, Authentiface, Inc. offers secure and efficient authentication solutions for software and commercial applications, using artificial intelligence and machine learning. With Authentiface, Inc., your face is your password. Join us in embracing a future where your face is the key to everything.

An early stage biotechnology company based in Salt Lake City developing safe and effective alternatives to opioids.

Buster is an AI-powered BI tool. With it, anyone can ask data questions in plain english, get back charts & build their own dashboards.

Inherent Biosciences is pioneering epigenetic medicine for complex diseases. Gene dysregulation, a hallmark of complex disease, has been difficult to detect and treat, until now... Our epigenetic platform detects dysregulation across multiple genes and related pathways. Were pioneering a new category of diagnostics and therapeutics that leverage epigenetics, biologys inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases like infertility, autoimmune disease, autism, and other complex diseases. Our first products help patients suffering from infertility. See our first product at: pathfertility.com

Eden Technologies RO Centrifuge is a novel desalination reverse osmosis innovation that allows for ultra-high pressure. Our invention uses centrifugal force to push water through existing, off-the-shelf filters to separate salt and other minerals from clean water. As of right now, we are focused on developing and integrating innovative technology to expand clean water access, globally.

3Helix develops and markets a novel collagen targeting technology, providing scientists and clinicians with new tools to investigate collagen pathology and to develop diagnostics and therapeutics for diseases with high collagen remodeling activities.

Venture capital for tomorrow’s greatest healthcare companies

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant challenges of male infertility. We recognize the critical gap in male fertility treatment and are committed to helping people on their path to parenthood. Our innovative in-vitro spermatogenesis (IVS) technology is poised to transform the fertility landscape, offering new hope and innovative solutions to those struggling to conceive. Led by a team of world-renowned scientists and physicians, we are advancing research into clinical applications. Our mission is to make parenthood a reality for more families through ethical, scientifically advanced fertility solutions. Did you know? *1 in 8 couples struggle with infertility. *50% of in vitro fertilization (IVF) procedures fail. *50% of infertility is linked to men. *Male infertility treatment has been stagnant since 1992. Paterna is the first to develop a truly new treatment for male infertility since then. With a strong foundation in science and a commitment to innovation, Paterna BioSciences is uniquely positioned to lead the next generation of male fertility treatments. We are actively seeking funding to accelerate our clinical development and commercialization efforts, bringing our life-changing technology to families worldwide. We help make parenthood possible. Learn more at www.PaternaBio.com Contact us: info@paternabio.com A New Paradigm in Human Reproduction.

Purgo Scientific is a medical device company developing a novel method for targeted therapeutic drug delivery. While there are many applications for this method, the initial goal is to treat and prevent biofilm-related surgical site infections that compromise indwelling devices such as orthopedic implants. Targeted drug delivery against biofilms with local, high dose concentrations of antibiotic have a better chance at treating these infections than other therapies. In the United States alone, each year this problem affects as many as 300,000 people and costs the healthcare system up to $10 billion. The ultimate goal for our device is to extend its application beyond the eradication of biofilm-caused infections, and to treat any health issue that benefits from precise medicine delivery, including pain and oncology applications.

Front desk tasks at a healthcare practice are time-consuming and largely repetitive. Stratus provides AI solutions that allows your practice to focus on what matters most – your patients.

Authentiface, Inc. is a startup that transforms authentication with its facial motion analysis technology. Based in Utah, Authentiface, Inc. offers secure and efficient authentication solutions for software and commercial applications, using artificial intelligence and machine learning. With Authentiface, Inc., your face is your password. Join us in embracing a future where your face is the key to everything.